Dr. Wray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2060 Lakeside Centre Way
Knoxville, TN 37922Phone+1 865-218-6222Fax+1 833-671-1059
Education & Training
- Duke University HospitalResidency, Neurology, 1995 - 1998
- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1994 - 1995
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1994
Certifications & Licensure
- TN State Medical License 1999 - 2025
- NC State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 69 citationsA phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis:Edward Fox, Amy E. Lovett-Racke, Matthew Gormley, Yue Liu, Maria Petracca
Multiple Sclerosis. 2021-03-01 - 58 citationsInfection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension s...Sibyl Wray, Eva Havrdova, David R. Snydman, Douglas L. Arnold, Jeffrey A. Cohen
Multiple Sclerosis. 2019-10-01 - 16 citationsEfficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.Bart Van Wijmeersch, Barry A Singer, Aaron Boster, Simon Broadley, Oscar Fernandez
Multiple Sclerosis. 2020-11-01
Press Mentions
- #AANAM – Vumerity Showing Tolerability, Efficacy in Ongoing EVOLVE-MS-1 TrialApril 28th, 2021
- #AANAM – RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of LifeMay 10th, 2019
- Relapsing Remitting MS Patients Who Received LemtradaMay 6th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: